Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 16 , ISSUE 6 ( November-December, 2024 ) > List of Articles

CASE REPORT

Fertility Preservation in Breast Carcinoma: The Way Forward

Priyanka H Vora, Kedar Ganla, Manjusha Ganla, Kairavi Gokani

Keywords : Breast cancer, Case report, Fertility preservation, Infertility, Ovum pick up, Reproductive medicine

Citation Information : Vora PH, Ganla K, Ganla M, Gokani K. Fertility Preservation in Breast Carcinoma: The Way Forward. J South Asian Feder Obs Gynae 2024; 16 (6):697-698.

DOI: 10.5005/jp-journals-10006-2548

License: CC BY-NC 4.0

Published Online: 19-11-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Fertility preservation is crucial to prevent the spread of cancer in younger adults, especially in women of reproductive age. A 30-year-old woman with breast cancer was referred for fertility preservation, despite having no family history of breast cancer. The couple was offered embryo cryopreservation before chemotherapy, and the procedure involved controlled ovarian stimulation (COS) with letrozole supplementation. The couple retrieved 13 oocytes, with 11 being metaphase 2 of which 9 fertilized. The oocytes were stimulated and monitored serially for blood estrogen levels. Fertility preservation is essential for improving the quality of life for cancer survivors and reducing concerns about increased estrogen levels in women with breast cancers. Multidisciplinary collaboration between oncologists and reproductive specialists is needed to improve awareness and availability. Early referral to a fertility specialist is essential for optimal results.


PDF Share
  1. Quinn MM, Cakmak H, Letourneau JM, et al. Response to ovarian stimulation is not impacted by a breast cancer diagnosis. Hum Reprod 2017;32(3):568–574. DOI: 10.1093/humrep/dew355.
  2. Ahmad MF, Sugishita Y, Suzuki-Takahashi Y, et al. Case report: Young adults with breast cancer: A case series of fertility preservation management and literature review. Front Med (Lausanne) 2021;8:670872. DOI: 10.3389/fmed.2021.670872.
  3. Shim YJ, Seol A, Lee D, et al. The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins. Obstet Gynecol Sci 2018;61(2):242–246. DOI: 10.5468/ogs.2018.61.2.242.
  4. Danis RB, Pereira N, Elias RT. Random start ovarian stimulation for oocyte or embryo cryopreservation in women desiring fertility preservation prior to gonadotoxic cancer therapy. Curr Pharm Biotechnol 2017;18(8):609–613. DOI: 10.2174/1389201018666170808122531.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.